238 related articles for article (PubMed ID: 19415900)
1. Small-molecule suppression of misfolding of mutated human carbonic anhydrase II linked to marble brain disease.
Almstedt K; Rafstedt T; Supuran CT; Carlsson U; Hammarström P
Biochemistry; 2009 Jun; 48(23):5358-64. PubMed ID: 19415900
[TBL] [Abstract][Full Text] [Related]
2. Unfolding a folding disease: folding, misfolding and aggregation of the marble brain syndrome-associated mutant H107Y of human carbonic anhydrase II.
Almstedt K; Lundqvist M; Carlsson J; Karlsson M; Persson B; Jonsson BH; Carlsson U; Hammarström P
J Mol Biol; 2004 Sep; 342(2):619-33. PubMed ID: 15327960
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamic interrogation of a folding disease. Mutant mapping of position 107 in human carbonic anhydrase II linked to marble brain disease.
Almstedt K; Mårtensson LG; Carlsson U; Hammarström P
Biochemistry; 2008 Feb; 47(5):1288-98. PubMed ID: 18189416
[TBL] [Abstract][Full Text] [Related]
4. Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes.
Kasimoğullari R; Bülbül M; Günhan H; Güleryüz H
Bioorg Med Chem; 2009 May; 17(9):3295-301. PubMed ID: 19362844
[TBL] [Abstract][Full Text] [Related]
5. Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: Potential membrane-impermeable inhibitors of carbonic anhydrase.
May JA; Namil A; Chen HH; Dantanarayana AP; Dupré B; Liao JC
Bioorg Med Chem; 2006 Mar; 14(6):2052-9. PubMed ID: 16297631
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases.
Nasr G; Petit E; Supuran CT; Winum JY; Barboiu M
Bioorg Med Chem Lett; 2009 Nov; 19(21):6014-7. PubMed ID: 19796939
[TBL] [Abstract][Full Text] [Related]
7. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices.
Melagraki G; Afantitis A; Sarimveis H; Igglessi-Markopoulou O; Supuran CT
Bioorg Med Chem; 2006 Feb; 14(4):1108-14. PubMed ID: 16213737
[TBL] [Abstract][Full Text] [Related]
8. A new synthesis of difluoromethanesulfonamides--a novel pharmacophore for carbonic anhydrase inhibition.
Boyle NA; Chegwidden WR; Blackburn GM
Org Biomol Chem; 2005 Jan; 3(2):222-4. PubMed ID: 15632962
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
10. Subtle differences in dissociation rates of interactions between destabilized human carbonic anhydrase II mutants and immobilized benzenesulfonamide inhibitors probed by a surface plasmon resonance biosensor.
Svedhem S; Enander K; Karlsson M; Sjöbom H; Liedberg B; Löfås S; Mårtensson LG; Sjöstrand SE; Svensson S; Carlsson U; Lundström I
Anal Biochem; 2001 Sep; 296(2):188-96. PubMed ID: 11554714
[TBL] [Abstract][Full Text] [Related]
11. Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II.
Banerjee AL; Swanson M; Roy BC; Jia X; Haldar MK; Mallik S; Srivastava DK
J Am Chem Soc; 2004 Sep; 126(35):10875-83. PubMed ID: 15339172
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.
Huang H; Pan X; Tan N; Zeng G; Ji C
Eur J Med Chem; 2007 Mar; 42(3):365-72. PubMed ID: 17118494
[TBL] [Abstract][Full Text] [Related]
13. Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors.
Kockar F; Maresca A; Aydin M; Işik S; Turkoglu S; Sinan S; Arslan O; Güler OO; Turan Y; Supuran CT
Bioorg Med Chem; 2010 Aug; 18(15):5498-503. PubMed ID: 20624682
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols.
Sentürk M; Gülçin I; Daştan A; Küfrevioğlu OI; Supuran CT
Bioorg Med Chem; 2009 Apr; 17(8):3207-11. PubMed ID: 19231207
[TBL] [Abstract][Full Text] [Related]
15. Reshaping the folding energy landscape of human carbonic anhydrase II by a single point genetic mutation Pro237His.
Jiang Y; Su JT; Zhang J; Wei X; Yan YB; Zhou HM
Int J Biochem Cell Biol; 2008; 40(4):776-88. PubMed ID: 18060825
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
[TBL] [Abstract][Full Text] [Related]
18. Reshaping the folding energy landscape by chloride salt: impact on molten-globule formation and aggregation behavior of carbonic anhydrase.
Borén K; Grankvist H; Hammarström P; Carlsson U
FEBS Lett; 2004 May; 566(1-3):95-9. PubMed ID: 15147875
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2007 Dec; 15(23):7229-36. PubMed ID: 17826101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
